S. Lippard

Molecular Biology · 2000–2016

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

Whom S. Lippard trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Davis

Who trusts S. Lippard overall

  1. Shaloam Dasari
  2. Chunyu Zhang
  3. P. Tchounwou

Papers from S. Lippard's perspective

Ordered by how strongly the researchers S. Lippard trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
  2. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system (Nature)
  3. Signal transduction by the JNK group of MAP kinases. (Cell)
  4. Nanoscale coordination polymers for platinum-based anticancer drug delivery. (Journal of the American Chemical Society)
  5. Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. (Chemical Reviews)
  6. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles (Molecular Pharmaceutics)
  7. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature)
  8. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 (Nature Genetics)
  9. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases (Nature reviews. Drug discovery)
  10. Requirement for ERK Activation in Cisplatin-induced Apoptosis* (Journal of Biological Chemistry)

Their papers